Reuters logo
Sanofi to pay $19.8 million over claims of drug overcharges - U.S.
April 3, 2017 / 3:30 PM / 6 months ago

Sanofi to pay $19.8 million over claims of drug overcharges - U.S.

A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo

WASHINGTON (Reuters) - Sanofi SA (SASY.PA)’s Sanofi-Pasteur unit has agreed to pay $19.8 million (15.88 million pounds) to resolve claims that it overcharged the U.S. Department of Veterans Affairs for medications between 2002 and 2011, U.S. Justice officials said on Monday.

Sanofi-Pasteur, the company’s vaccine division, had told the Veterans Affairs (VA) Department in 2012 that it had made an accounting error in overcharging for certain drugs, the Justice Department said in a statement.

In an emailed statement, a Sanofi spokeswoman said the company “cooperated fully and negotiated in good faith with the government.”

Reporting by Joel Schectman and Susan Heavey; Editing by James Dalgleish

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below